|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168 00020
|
$5,855,332
|
$1,171,066
|
Hoover, Robert
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
5P30CA091842-17
|
$4,207,812
|
$589,094
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Quantitative and functional characterization of therapeutic resistance in cancer
|
5U54CA217377-02
|
$2,054,998
|
|
MANALIS, SCOTT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Clinical and Genetic Studies of Li Fraumeni Syndrome
|
ZIA CP010144 10503
|
$1,976,426
|
$395,285
|
Savage, Sharon
|
DCEG (NCI)
|
|
Laboratory of Translational Genomics
|
ZIA CP010201 10410
|
$1,976,411
|
$98,821
|
Dean, Michael
|
DCEG (NCI)
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
5P01CA019014-39
|
$1,812,080
|
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$33,055
|
Alter, Blanche
|
DCEG (NCI)
|
|
Mechanisms of Esophageal Carcinogenesis
|
5P01CA098101-15
|
$1,607,533
|
|
RUSTGI, ANIL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Determinants of Cancer Therapeutic Response
|
5P01CA077852-19
|
$1,458,213
|
|
MONNAT, RAYMOND
|
UNIVERSITY OF WASHINGTON
|
|
Proteogenomic Translational Research Center for Clinical Proteomic
|
5U01CA214116-02
|
$1,372,508
|
|
RODLAND, KARIN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
5P01CA016038-44
|
$980,728
|
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-19
|
$961,183
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-03
|
$954,328
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Clinical Oncology Research Program (CORP)
|
2K12CA076917-21
|
$945,630
|
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology
|
2K12CA087723-16
|
$899,049
|
|
GRAUBERT, TIMOTHY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The TOPAS Tool for Particle Simulation, a Monte Carlo Simulation Tool for Physics, Biology and Clinical Research
|
1U24CA215123-01A1
|
$866,409
|
|
FADDEGON, BRUCE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Resistance Training to Reduce Chemotoxicity in Colon Cancer
|
5R01CA206196-02
|
$863,821
|
|
CAAN, BETTE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Second cancers after breast cancer in the Kaiser cohort
|
ZIA CP010131 10493
|
$863,614
|
$431,807
|
Berrington, Amy
|
DCEG (NCI)
|
|
Biofilm Epidemiology and Mechanisms in Colon Cancer
|
5R01CA196845-03
|
$862,426
|
|
SEARS, CYNTHIA
|
JOHNS HOPKINS UNIVERSITY
|
|
Endogenous hormones and postmenopausal breast cancer: Etiologic insights and improving risk prediction
|
5R01CA207369-02
|
$850,128
|
$850,128
|
HANKINSON, SUSAN
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
Trinity: Transcriptome assembly for genetic and functional analysis of cancer
|
2U24CA180922-06
|
$821,203
|
|
REGEV, AVIV
|
BROAD INSTITUTE, INC.
|
|
PLCO - Breast Cancer
|
ZIA CP010152 10023
|
$809,184
|
$809,184
|
Hoover, Robert
|
DCEG (NCI)
|
|
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
|
1R01CA227073-01
|
$769,591
|
|
DUCKETT, DEREK
|
SCRIPPS FLORIDA
|
|
PET nanoreporter image-guided breast cancer therapy
|
1R01CA220234-01A1
|
$758,800
|
$758,800
|
MULDER, WILLEM
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
|
5R01CA196590-03
|
$752,970
|
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
ABCD-USA Consortium: Data Analysis Center
|
5U24DA041123-04
|
$750,000
|
|
DALE, ANDERS
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
ABCD-USA Consortium: Coordinating Center
|
5U24DA041147-04
|
$750,000
|
|
JERNIGAN, TERRY
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic
|
5K12CA090628-18
|
$746,756
|
|
JATOI, AMINAH
|
MAYO CLINIC ROCHESTER
|
|
Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
|
5R01CA193673-03
|
$735,322
|
$735,322
|
SHELBY, REBECCA
|
DUKE UNIVERSITY
|
|
Optimizing Tobacco Dependence Treatment in the Emergency Department
|
5R01CA201873-03
|
$730,670
|
|
BERNSTEIN, STEVEN
|
YALE UNIVERSITY
|
|
Imaging tumor and T cell responses to metabolic and immune modulation therapy
|
5R01CA215136-02
|
$712,992
|
$712,992
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Supporting and evolving Gene Set Enrichment Analysis and the Molecular Signatures Database for cancer research
|
1U24CA220341-01A1
|
$707,395
|
|
MESIROV, JILL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Devaluing Energy-Dense Foods for Cancer Control: Translational Neuroscience
|
5R01CA211224-02
|
$705,027
|
|
BERKMAN, ELLIOT
|
UNIVERSITY OF OREGON
|
|
Helping the poor quit smoking: specialized quitlines and meeting basic needs
|
5R01CA201429-03
|
$694,360
|
|
KREUTER, MATTHEW
|
WASHINGTON UNIVERSITY
|
|
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
|
5R01CA217956-02
|
$688,403
|
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection
|
1R01CA218500-01A1
|
$677,886
|
|
IVANOV, ALEXANDER
|
NORTHEASTERN UNIVERSITY
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-18
|
$672,442
|
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SBIR grant application to develop and commercialize a urine based medical diagnostic for the detection of bladder cancer recurrence.
|
5R44CA200174-03
|
$670,314
|
|
LEVIN, TREVOR
|
UROLOGY DIAGNOSTICS, INC.
|
|
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
|
1R01CA218382-01A1
|
$668,549
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-34
|
$666,666
|
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
VU PREDICT
|
1U24CA220325-01A1
|
$664,613
|
|
MANNING, HENRY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
|
5R01CA198089-04
|
$663,135
|
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Large-Area Plasma Panel Detectors for Particle Beam Radiation Therapy
|
5R44CA183437-04
|
$661,437
|
|
FRIEDMAN, PETER
|
INTEGRATED SENSORS, LLC
|
|
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
|
5U01CA213333-02
|
$661,067
|
|
WONG, KWOK KIN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
|
5R01CA194321-03
|
$660,603
|
|
HUMM, JOHN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
|
5R01CA204924-03
|
$657,305
|
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
|
5R01CA212162-02
|
$650,403
|
|
NOVAK, ANNE
|
MAYO CLINIC ROCHESTER
|
|
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
|
5R01CA217953-02
|
$643,560
|
|
WINTERMARK, MAX
|
STANFORD UNIVERSITY
|
|
Sleep Disturbance, Inflammation, and Cellular Aging in Breast Cancer Survivors
|
5R01CA207130-03
|
$643,101
|
$643,101
|
IRWIN, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
|
1R01CA227687-01
|
$639,521
|
|
BUTTS-PAULY, KIM
|
STANFORD UNIVERSITY
|
Total relevant funding to Breast for this search: $37,943,241
|